Protalix BioTherapeutics, Inc. (PLX)

Import this data to Google Sheets with:

=jivedata("PLX","financials")

Full statements spill as a table. For one cell: =jivedata("PLX","Revenue") or =jivedata("PLX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Protalix BioTherapeutics, Inc.

PLX • CIK 0001006281

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenues	$65,494	$53,399	$52,744	$80,619
Cost of Revenue	$22,982	$24,319	$26,993	$24,832
Research and Development Expense	$17,093	$12,970	$19,569	$19,879
Selling, General and Administrative Expense	$14,959	$12,193	$11,682	$12,617
Operating Income (Loss)	$10,460	$3,917	$-5,500	$23,291
Other Nonoperating Income	$1,286	$1,299	$1,083	$1,401
Nonoperating Income (Expense)	$-1,894	$237	$-108	$173
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$8,566	$4,154	$-5,608	$23,464
Income Tax Expense (Benefit)	$254	$1,222	$996	$4,519
Net Income (Loss) Attributable to Parent	$8,312	$2,932	$-6,604	$18,945
Weighted Average Number of Shares Outstanding, Basic	67,512,527	72,530,698	78,546,234	80,779,466
Weighted Average Number of Shares Outstanding, Diluted	82,424,016	81,057,176	78,546,234	83,705,415

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$23,634	$19,760	$14,680	$27,420
Restricted Cash and Cash Equivalents, Current	—	—	$702	$720
Assets	$84,434	$73,417	$82,346	$110,336
Accounts Receivable, after Allowance for Credit Loss, Current	$5,272	$2,909	$8,840	$16,503
Other Assets, Current	$1,055	$1,096	$1,129	$2,049
Inventory, Net	$19,045	$21,243	$25,729	$32,292
Assets, Current	$69,932	$60,078	$66,673	$92,220
Assets for Plan Benefits, Defined Benefit Plan	$528	$462	$578	$589
Property, Plant and Equipment, Net	$4,973	$4,591	$4,879	$5,467
Deferred Income Tax Assets, Net	$3,092	$2,856	$2,516	$2,374
Liabilities, Noncurrent	$5,335	$4,585	$7,598	$7,541
Operating Lease, Right-of-Use Asset	$5,909	$5,430	$7,700	$8,175
Liabilities	$50,865	$30,206	$34,116	$38,932
Stockholders' Equity Attributable to Parent	$33,569	$43,211	$48,230	$71,404
Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent	$714	$559	$661	$671
Operating Lease, Liability, Noncurrent	$4,621	$4,026	$6,937	$7,541
Common Stock, Value, Issued	$73	$76	$80	$80
Additional Paid in Capital, Common Stock	$415,045	$421,528	$433,147	$433,147
Retained Earnings (Accumulated Deficit)	$-381,549	$-378,393	$-384,997	$-384,997
Accounts Payable, Trade, Current	$4,320	$4,533	$5,259	$6,506
Operating Lease, Liability, Current	$1,409	$1,500	$1,384	$1,666
Liabilities, Current	$45,530	$25,621	$26,518	$31,391
Common Stock, Shares Authorized	185,000,000	185,000,000	185,000,000	185,000,000
Common Stock, Shares, Issued	72,952,124	75,850,275	80,425,981	80,425,981

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$8,312	$2,932	$-6,604	$18,945
Net Cash Provided by (Used in) Operating Activities	$-1,318	$8,674	$-11,993	$9,923
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations	$-114	$25	$-47	$334
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$6,523	$-3,874	$-5,080	$9,525
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$23,634	$19,760	$14,680	$36,223
Share-based Payment Arrangement, Noncash Expense	$3,448	$3,253	$2,297	$2,260
Depreciation	$1,191	$1,304	$1,465	$1,569
Foreign Currency Transaction Gain (Loss), Unrealized	$446	$-310	$-606	$-1,227
Payments to Acquire Property, Plant, and Equipment	$1,149	$1,282	$1,638	$2,255
Pension and Other Postretirement Benefits Cost (Reversal of Cost)	$3	$-151	$22	$-47
Proceeds from Sale of Property, Plant, and Equipment	$0	$3	$0	$0
Deferred Income Tax Expense (Benefit)	$-3,092	$236	$340	$364
Payments for (Proceeds from) Other Investing Activities	$142	$-80	$26	$53
Gain (Loss) on Disposition of Property Plant Equipment	$-9	$3	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-16,711	$4,221	$-2,366	$-1,028
Amortization of Debt Issuance Costs and Discounts	$267	$0	$0	$0
Repayments of Convertible Debt	$0	$20,420	$0	$0
Proceeds from Issuance of Common Stock	$23,954	$3,626	$6,812	$6,812
Net Cash Provided by (Used in) Financing Activities	$24,666	$-16,794	$9,326	$296
Capital Expenditures Incurred but Not yet Paid	$614	$254	$369	$404
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$1,567	$376	$3,185	$3,989
Debt Conversion, Converted Instrument, Amount	$7,783	$0	$0	$0
Income Taxes Paid, Net	—	$385	$1,183	$1,183
Interest Paid, Excluding Capitalized Interest, Operating Activities	$2,742	$1,532	$0	$0
Increase (Decrease) in Contract with Customer, Liability	$-13,178	$0	$0	$0
Increase (Decrease) in Accounts Receivable	$428	$-2,317	$5,890	$7,597
Increase (Decrease) in Inventories	$2,241	$2,198	$4,486	$11,161
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$5,295	$696	$292	$6,359

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("PLX","financials")

Full statements spill as a table. For one cell: =jivedata("PLX","Revenue") or =jivedata("PLX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.